Business · 09/07/2018Updated: 10/17/2026 · 1 min read
FDA Releases Revised Guidance on Reducing Zika Virus Risk in Blood and Blood Components
Summary
The Food and Drug Administration has released a final guidance document providing revised recommendations to reduce the risk of Zika virus transmission through blood and blood components, replacing an August 2016 guidance.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →